MajorBoko
Member
Moderna Starts COVID Vaccine Study For Children Under 12
CAMBRIDGE – Moderna has started a study of its coronavirus vaccine in children under the age of 12.
boston.cbslocal.com
The Cambridge-based company announced Tuesday that the first participants in the research – ages 6 months to less than 12 years – have received doses.
The two-part study is designed to show how children tolerate the vaccine, and to make sure it’s safe and effective for them. This expands the age bracket of Moderna’s study which started with kids ages 12 to 17.
Moderna’s vaccine is two shots given 28 days apart.
The study, called kidCOVE, is expected to enroll 6,750 healthy children in the U.S. and Canada. As with earlier studies, some will receive the vaccine and others will get a placebo. Moderna said the placebo is a “saltwater solution that looks just like the study vaccine but contains no active vaccine.”
The children will be followed for a year after their second vaccination.
“It’s a very interesting and exciting development,” Dr. Rick Malley, a physician in the Division of Infectious Diseases at Boston Children’s Hospital, told WBZ-TV. “It’s very important to try to get as many people vaccinated safely as possible and children represent a very large chunk of our population. We want them to be safe, we want schools to be functioning at full capacity.”
CAMBRIDGE – Moderna has started a study of its coronavirus vaccine in children under the age of 12.
CBS Boston - Breaking News, Sports, Weather, I-Team Investigations
Latest breaking news from WBZ-TV CBS Boston.
boston.cbslocal.com
The Cambridge-based company announced Tuesday that the first participants in the research – ages 6 months to less than 12 years – have received doses.
The two-part study is designed to show how children tolerate the vaccine, and to make sure it’s safe and effective for them. This expands the age bracket of Moderna’s study which started with kids ages 12 to 17.
Moderna’s vaccine is two shots given 28 days apart.
The study, called kidCOVE, is expected to enroll 6,750 healthy children in the U.S. and Canada. As with earlier studies, some will receive the vaccine and others will get a placebo. Moderna said the placebo is a “saltwater solution that looks just like the study vaccine but contains no active vaccine.”
The children will be followed for a year after their second vaccination.
“It’s a very interesting and exciting development,” Dr. Rick Malley, a physician in the Division of Infectious Diseases at Boston Children’s Hospital, told WBZ-TV. “It’s very important to try to get as many people vaccinated safely as possible and children represent a very large chunk of our population. We want them to be safe, we want schools to be functioning at full capacity.”
